29 Nov 2019 --- A new three-strain probiotic blend from Chr. Hansen may help support intestinal health and development in preterm babies. It has been shown to reduce the risk of Necrotizing enterocolitis (NEC) by 50 percent, notes the company. NEC is an inflammatory disease and is the leading cause of mortality worldwide for preterm babies. Now launched through customer partnerships in the US and in Europe, Chr. Hansen’s new product is already being used in some neonatal intensive care units, fed to babies through a feeding tube.
